Aktiesnakken — Juni 2011
-
men h+h lukkede rimeligt meget af for processen da de besluttede at hyre ny direktør
-
xella har ikke rigtigt givet et tilbud på de 67,5 og H+H har ikke rigtigt tilkendegivet noget
-
så du skal nærmere spørge: hvad kan få handlen i gang igen?
-
Xella brugte EU godkendelse som undskyldning
-
nej det tror jeg ikke
-
er du stadig i den masha?
-
-
i max?
-
det betyder noget! trust me
-
Så nu vil genmab længere ned..

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
